Impact of Cirrhosis Outcome Risk Estimator (CORE) Risk Score on Prognosis Following Hepatectomy for Hepatocellular Carcinoma.

Authors

Kosei Takagi, Takeyoshi Nishiyama, Jiro Kimura, Tomokazu Fuji, Kazuya Yasui, Toshiyoshi Fujiwara

Published in

Anticancer research. Volume 46. Issue 9. Pages 4993-5001.

Abstract

Several studies have reported the clinical value of prognostic markers in patients with hepatocellular carcinoma (HCC). However, no study has examined the clinical significance of the Cirrhosis Outcome Risk Estimator (CORE) risk score on outcomes. This study aimed to investigate the impact of CORE risk score on survival in patients undergoing hepatectomy for HCC.
This single-center retrospective study included 639 patients who underwent hepatectomy for HCC between January 2004 and December 2023. Clinical parameters were compared between the low (≤2.4) and high (>2.4) CORE score groups. Multivariate analyses were performed to assess the impact of the CORE risk score on outcomes.
Patients in the high CORE score group had significantly worse 5-year overall (58.9% vs. 80.4%; p<0.001) and recurrence-free (32.9% vs. 52.5%; p<0.001) survival rates than the low CORE score group. Multivariable analyses indicated high CORE risk score as an independent prognostic factor for poor overall [hazard ratio (HR)=1.84; 95% confidence interval (CI)=1.38-2.43; p<0.001] and recurrence-free (HR=1.38; 95%CI=1.09-1.75; p=0.007) survival.
The CORE risk score, an easily accessible screening test, may be a reliable predictor of survival in patients undergoing hepatectomy for HCC.

PMID:
42674693
Bibliographic data and abstract were imported from PubMed on 01 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.